New York Times reports on price cuts for HPV vaccine

Thanks to Pap tests, fatal cervical cancers are almost unknown today in rich countries. But the disease kills an estimated 275,000 women a year in poor countries where Pap tests are impractical and the vaccine is far too expensive for the average woman to afford, so the price cut could lead to a significant advance in women’s health.

Last week in separate deals with the GAVI Alliance, the drug companies Pfizer and GlaxoSmithKline (GSK) agreed to increase sales of cut-price pneumonia vaccines by 180 million doses, a 50% increase from previous commitments.

Sabin Vaccine Institute To Honor Pharmaceutical Chief Executive and U.S. Diplomat at New York City Benefit Dinner

NEW CANAAN, CT—The Sabin Vaccine Institute presents its two highest non-science awards on May 30 to Jean-Pierre Garnier, PhD, Chairman and Chief Executive Officer of GlaxoSmithKline, and The Honorable Richard C. Holbrooke, Former U.S. Permanent Representative to the United Nations. Garnier will receive Sabin’s Humanitarian Award and Holbrooke will receive the Institute’s Lifetime Achievement Award at a benefit dinner at The Pierre Hotel in New York City.

Subscribe to RSS - GlaxoSmithKline